According to the authors, as a leading agricultural state, Texas is poised to become the new leader in hemp production, whether for medicinal or industrial purposes.
Fellow Katharine Neill Harris considers the validity of risk assessment tools, which estimate the likelihood that an individual who has been charged with or convicted of a crime will commit a future offense. Baker Institute Blog: https://bit.ly/2Cwl6jc
Body-worn cameras (BWCs) are becoming a permanent fixture of modern policing, and their effects are likely to be much more nuanced than originally predicted.
Despite the wealth of evidence attesting to the efficacy of medication-assisted treatment for opioid addiction, the majority of Americans who need it can't get it — including in Harris County, Texas’ largest county. Baker Institute Blog: https://bit.ly/31D9qGV
According to the authors, developments in cannabis law, arbitration clause interpretation and the economic loss doctrine show that numerous facets of business litigation are changing rapidly.
The Commission on Combatting Drug Addiction and the Opioid Crisis appointed by President Trump released its report on Monday, July 31. Drug policy fellow Katharine Neill Harris assesses the commission's recommendations in the Baker Institute Blog.
Drug policy fellow Katharine A. Neill explains why establishing heroin-assisted treatment programs, which provide severely addicted individuals with controlled access to pharmaceutical-grade heroin, could make a significant dent in the number of U.S. deaths from opioid use in this post for the Baker Institute Blog.
The Texas House of Representatives is considering House Bill 3256, which would legalize syringe exchange programs (SEPs) as a means of reducing the transmission of infectious and communicable diseases among people who inject drugs. On April 25, William Martin, director of the Drug Policy Program, appeared before the Texas House Committee on Public Health to testify in support of HB 3256. Martin also authored an op-ed in TribTalk supporting the establishment of SEPs.
The U.S. prosecution of drug kingpin El Chapo Guzman could open a Pandora’s box that exposes corrupt officials in both countries, writes fellow Gary Hale in the Baker Institute Blog.
Understood in its regional context, Philippines President Rodrigo Duterte’s war on drugs appears to be a continuation rather than a departure from Southeast Asian drug policy.